Fingolimod is used to treat relapsing remitting multiple sclerosis (MS). This type of MS involves recurrent acute episodes (relapses), with symptoms suddenly increasing or new symptoms developing. This is followed by periods when symptoms improve or even disappear altogether (remissions). Fingolimod belongs to a group of medicines called disease-modifying therapies which help to slow or reduce the worsening of disability in people with relapsing remitting MS.
Fingolimod acts on certain types of white blood cells called lymphocytes.
- In MS, these small lymphocyte cells play a role in destroying myelin, the protective sheath that surrounds the nerve fibres and helps with the efficient flow of nerve signals or messages to and from the brain and various parts of the body.
- Fingolimod helps prevent lymphocytes leaving the lymph nodes.
- This lowers the number of lymphocytes circulating in the blood and reaching the central nervous system, which in turn reduces damage to the nerve cells in the brain and spinal cord.
-
Read more about multiple sclerosis.